DR. SHREYA SHAH

DR. MEHUL SHAH, DR. APEKSHA KATARIA, DR. DEEKSHA THORAT

Abstract

INTRODUCTION:PARVOCELLULAR STIMULATION IS NOVEL THERAPY OF AMBLYOPIA IRRESPECTIVE OF AGE.

MATERIALS AND METHODS: THIS IS A PROSPECTIVE STUDY WHERE WE ENROLLED PATIENTS WITH AMBLYOPIA.ALL SENSORY AND MOTOR DOCUMENTATION DONE PATIENTS UNDERWENT AVERAGE 3-10 SESSIONS, EACH SESSION LASTING FOR MINIMUM 60 MINUTES.VISION WAS RECORDED USING ETDRS VISION CHARTS AND PATIENTS WERE EVALUATED FOR IMPROVEMENT IN VISION.ALL DATA COLLECEED IN PRE TESTED ONLINE DATA FORMAT AND PRE AND POST TREATMENT DATA ANALYZED.WITH SPSS 22.DESCRIPTIVE AND CROSS TABULATION USED FOR ANALYSES.P VALUE <0.05 CONSIDERED STASTICALLY SIGNIFICANT RESULTS: OUR COHORT WAS CONSISTED OF24 PATIENTS 13M ,11 F WITH MEAN AGE 14.88+/- 8.3 YEARS AT END OF TREATMENT WE FOUND SIGNIFICANT IMPROVEMENT IN NEAR VISION(P=0.04)WITH MEAN FOLLOW UP OF 25 DAYS. CONCLUSION: PARVOCELLULAR STIMULATION EFFECTIVE FOR IMPROVEMENT IN VISION OF AMBLYOPIC PATIENTS IRRESPECTIVE OF AGE